Literature DB >> 11427453

Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse.

A Helander1, G Eriksson, H Stibler, J O Jeppsson.   

Abstract

BACKGROUND: Isoforms of transferrin interfere with measurement of carbohydrate-deficient transferrin (CDT) as a marker of heavy alcohol consumption. We evaluated the rate of inaccurate CDT results by immunoassays.
METHODS: We studied 2360 consecutive sera (1614 individuals) submitted for CDT assay without clinical information as well as samples from 1 patient with a congenital disorder of glycosylation (CDG Ia) and from 6 healthy carriers of CDG Ia. The CDTect, %CDT-TIA, and new %CDT immunoassays were compared with HPLC (%CDT-HPLC). Transferrin isoform pattern were evaluated by isoelectric focusing (IEF).
RESULTS: Transferrin BC and CD heterozygotes were found at frequencies of approximately 0.7% and approximately 0.2%, respectively. Another transferrin C subtype, where di- and trisialotransferrin partly coeluted (tentatively identified as C2C3), was observed in approximately 0.6%. Compared with the %CDT-HPLC method, the immunoassays often produced low results for transferrin BC and high results for transferrin CD and "C2C3". A very high trisialotransferrin value (frequency approximately 1%) often produced high CDT immunoassay results. In four of six healthy carriers of CDG Ia, a- and disialotransferrin were highly increased and the HPLC and IEF isoform patterns were indistinguishable from those in alcohol abuse.
CONCLUSIONS: Rare transferrin isoform types and abnormal amounts of trisialotransferrin (total frequency approximately 2-3%) may cause incorrect determination of CDT with immunoassays. The observed variants were readily identified by HPLC and IEF, which can be recommended for verification of CDT immunoassay results in doubtful cases. In healthy carriers of CDG Ia, CDT is high by all assays.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427453

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  19 in total

1.  Abnormal Glycosylation Profile and High Alpha-Fetoprotein in a Patient with Twinkle Variants.

Authors:  Juliette Bouchereau; Sandrine Vuillaumier Barrot; Thierry Dupré; Stuart E H Moore; Ruxandra Cardas; Yline Capri; Pauline Gaignard; Abdelhamid Slama; Catherine Delanoë; Hélène Ogier de Baulny; Nathalie Seta; Manuel Schiff; Laurent Servais
Journal:  JIMD Rep       Date:  2016-02-27

2.  Genome-wide association study identifies two loci strongly affecting transferrin glycosylation.

Authors:  Zoltán Kutalik; Beben Benyamin; Sven Bergmann; Vincent Mooser; Gérard Waeber; Grant W Montgomery; Nicholas G Martin; Pamela A F Madden; Andrew C Heath; Jacques S Beckmann; Peter Vollenweider; Pedro Marques-Vidal; John B Whitfield
Journal:  Hum Mol Genet       Date:  2011-06-10       Impact factor: 6.150

3.  Exclusion of trisialo-transferrin from carbohydrate-deficient transferrin measurement: advantage in patients with chronic liver disease?

Authors:  Maximilian Schöniger-Hekele; Katrin Ramskogler; Doris Hartl; Otto M Lesch; Christian Müller
Journal:  Wien Med Wochenschr       Date:  2006-04

4.  Advanced gestational age increases serum carbohydrate-deficient transferrin levels in abstinent pregnant women.

Authors:  Ludmila N Bakhireva; Sandra Cano; William F Rayburn; Renate D Savich; Lawrence Leeman; Raymond F Anton; Daniel D Savage
Journal:  Alcohol Alcohol       Date:  2012-08-08       Impact factor: 2.826

5.  Relationship of Abnormal Chromatographic Pattern for Carbohydrate-Deficient Transferrin with Severe Liver Disease.

Authors:  Scott H Stewart; Adrian Reuben; Raymond F Anton
Journal:  Alcohol Alcohol       Date:  2016-10-07       Impact factor: 2.826

6.  Comparison of transferrin isoform analysis by capillary electrophoresis and HPLC for screening congenital disorders of glycosylation.

Authors:  Mihika B Dave; Alpa J Dherai; Vrajesh P Udani; Anaita U Hegde; Neelu A Desai; Tester F Ashavaid
Journal:  J Clin Lab Anal       Date:  2017-02-25       Impact factor: 2.352

7.  News on Clinical Details and Treatment in PGM1-CDG.

Authors:  Esther Schrapers; Laura C Tegtmeyer; Gunter Simic-Schleicher; Volker Debus; Janine Reunert; Sebastian Balbach; Karin Klingel; Ingrid Du Chesne; Anja Seelhöfer; Manfred Fobker; Thorsten Marquardt; Stephan Rust
Journal:  JIMD Rep       Date:  2015-08-25

8.  5- and 6-glycosylation of transferrin in patients with Alzheimer's disease.

Authors:  Susan J van Rensburg; Peter Berman; Felix Potocnik; Pam MacGregor; Dinie Hon; Nico de Villiers
Journal:  Metab Brain Dis       Date:  2004-06       Impact factor: 3.584

9.  Carbohydrate-Deficient Transferrin Determination in a Clinical Setting: Consistency Between Capillary Electrophoresis Assays and Utility of HPLC as a Confirmatory Test.

Authors:  Agnese Veronesi; Cristina Rota; Tommaso Trenti; Elisabetta Cariani
Journal:  J Clin Lab Anal       Date:  2015-10-26       Impact factor: 2.352

Review 10.  International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management.

Authors:  Ruqaiah Altassan; Silvia Radenkovic; Andrew C Edmondson; Rita Barone; Sandra Brasil; Anna Cechova; David Coman; Sarah Donoghue; Kristina Falkenstein; Vanessa Ferreira; Carlos Ferreira; Agata Fiumara; Rita Francisco; Hudson Freeze; Stephanie Grunewald; Tomas Honzik; Jaak Jaeken; Donna Krasnewich; Christina Lam; Joy Lee; Dirk Lefeber; Dorinda Marques-da-Silva; Carlota Pascoal; Dulce Quelhas; Kimiyo M Raymond; Daisy Rymen; Malgorzata Seroczynska; Mercedes Serrano; Jolanta Sykut-Cegielska; Christian Thiel; Frederic Tort; Mari-Anne Vals; Paula Videira; Nicol Voermans; Peter Witters; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2020-09-15       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.